Agreement Stem Cells

The HumEn project – Upscaling human insulin-producing beta cell production by efficient differentiation and expansion of endoderm progenitors – was funded by the European Union`s Seventh Research, Technological Development and Demonstration Programme under Grant Agreement No [602587]. Resnik, D. The need for international agreements on stem cells. Nat Biotechnol 22, 1207 (2004). In Ireland, such research is and will remain prohibited, but its representative, Micheál Martin, supported the agreement. „We must meet the challenges of contemporary science and respect the rights of other member states. This is a delicate but achievable compromise between different points of view,” he said. Nations should cooperate separately and together to develop strong and viable national and international policies for research on HE cells and their potential therapeutic use. Although different countries disagree on important bioethical issues related to HE cell research, such as reproductive cloning and abortion, it should be possible to reach agreement on some commonalities, such as the need for an international moratorium on reproductive cloning and the importance of informed consent, security and privacy in the field of biomedical therapy and research. Different geographic policies may also encourage stem cell researchers and research sponsors to migrate to nations or states with „ES cell-friendly” laws and guidelines.

Countries that allow research on ES cells, such as Britain and Singapore, have already shown that they are able to withdraw scientific resources from countries that avoid research, such as Germany and France. The potential for brain drain from ES cells could undermine scientific cooperation and weigh on international relations. ES Cell International is a regenerative medicine company that focuses on the development of therapeutic products from human embryonic stem cells (HES). ES Cell International was founded in Singapore in July 2000. The company`s head office is located with its own research and production site in a leading Australian medical research area. ES Cell International funds research cooperation with the Monash Institute of Reproduction and Development (Australia), the National University of Singapore (Singapore), the Hadassah Medical Organisation (Israel) and the Hubrecht Laboratory (Netherlands). „This agreement is of great importance to ES Cell International. It will ensure that we will be able to widely distribute our cell lines through the NIH`s extensive network of stem cell researchers, while maintaining our primary perspective on therapeutic product development,” said Robert Klupacs, CEO of ES Cell International.

„NIH researchers and those who are part of their collaborative networks are among the best in the world and all of us in this field will benefit from their contributions…


Sprawdź również

Dla Novation Agreement

(S-90) (a) The Office of Counsel shall inform contract staff of the proposed suspension or ...